Protalix Biotherapeutics

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$13,474
$3,748
$10,486
$10,345
Gross Profit
4,018
1,146
1,630
5,452
EBITDA
-2,108
-4,534
-5,302
-1,887
EBIT
-2,427
-4,856
-5,615
-2,192
Net Income
-2,203
-4,595
-6,044
-1,852
Net Change In Cash
13,474
3,748
10,486
10,345
Free Cash Flow
-3,782
3,589
3,345
-7,335
Cash
23,399
27,209
23,634
20,408
Basic Shares
73,308
73,036
72,952
83,782

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$65,494
$47,638
$38,350
$62,898
Gross Profit
42,512
28,046
22,001
52,025
EBITDA
11,651
-10,782
-20,061
3,148
EBIT
10,460
-11,868
-21,179
1,846
Net Income
8,312
-14,927
-33,985
-14,892
Net Change In Cash
65,494
47,638
38,350
62,898
Free Cash Flow
-2,467
-25,628
-11,744
-26,761
Cash
23,634
17,111
38,985
18,265
Basic Shares
82,424
48,472
44,140
29,148

Earnings Calls

Quarter EPS
2024-06-30
-$0.03
2024-03-31
-$0.06
2023-12-31
-$0.07
2023-09-30
-$0.04